Citations

Mayo Clinic

Clear

669 citation(s) found for "Xu, Can".

051 Can We Automatically Produce Generic Decision Aids for the Clinical Encounter Directly from GRADE Guideline Recommendations? Experience from the Share-It Project
Brandt, Linn , Heen, A Anja, Kristiansen, A, Neumann, I, Montor, V, Vandvik, Per Olav , Agoritsas, Thomas , Alonso‐Coello, Pablo , Akl, Elie A. , Tikkinen, Kari A.O. , Guyatt, Gordon

BMJ Quality & Safety | August 15, 2013 | Volume: 22 | Issue: Suppl 1 | Pages: A28.2-A28

10.1136/bmjqs-2013-002293.82 Get It

Background Although decision aids (DA) can help to communicate evidence to patients, their production is time consuming, often not based on the best available evidence or rapidly outdated. Linking trustworthy guidelines and DA for shared-decision making could both overcome these limitations and enhance guideline dissemination. Objectives To test the feasibility of automatically translating any recommendations from GRADE guidelines into generic and interactive DA accessible on tablet computers for clinicians and their patients in the clinical encounter. Methods As part of the DECIDE project, we developed a framework for translating components of GRADE into DA, following the International Patient Decision Aid Standards. Using a recently published guideline, we implemented that framework in our MAGIC (Making Grade the Irresistible Choice) application – a prototype electronic guideline tool and publication platform that can automatically display recommendations in multilayered presentation formats. Results Our prototype was able to automatically translate a large number of GRADE recommendations and their supporting evidence into electronic and interactive DA. Preliminary results of user-testing in real patient-clinician interactions suggest that these DA can be used at the point of care to discuss estimates of treatment effects for patient relevant outcomes, confidence in estimates, burden of treatment, and cost issues. Discussion This study provides a proof-of-concept that components of GRADE recommendations can be interactively displayed in generic tools for interactive shared-decision making in a wide range of treatment alternatives. Implications for Guideline Developers/Users Our electronic DA offer promising opportunities to disseminate guidelines at the point of care.
Can pillar suturing promote efficacy of adenotonsillectomy for pediatric osas? A prospective randomized controlled trial
Chiu, Po‐Han, Ramar, Kannan , Chen, Kuang‐Chao, Tsai, Yih‐Jeng , Lin, Chia‐Mo, Chiang, Yuh‐Chyun, Lu, Chia‐Ying, Chiang, Rayleigh Ping‐Ying , Chiu, Po-Han

The Laryngoscope | August 5, 2013 | Volume: 123 | Issue: 10 | Pages: 2573-2577

10.1002/lary.24011 | PMID 23918531 Get It

Objectives/Hypothesis Pediatric obstructive sleep apnea syndrome ( OSAS ) is a common disorder with serious clinical implications if left untreated. The recommended initial treatment for pediatric patients with obstructive sleep apnea syndrome ( OSAS ) is adenotonsillectomy. However, recent reports have shown variable surgical results with adenotonsillectomy in the treatment of pediatric OSAS . Study Design Prospective, controlled study. Methods From April 2007 to August 2010, 24 participants were assigned alternatively to either adenotonsillectomy with pillar suturing (intervention group) or adenotonsillectomy alone (control group). Result The average improvement in apnea hypopnea index ( AHI ) was 42.6% in the control group and 79.9% in the intervention group ( P =0.037). The success rate was 50% in the control group and 91.6% in the intervention group ( P =0.034). Six patients (50%) in the intervention group achieved complete resolution of pediatric OSAS , as defined by an AHI <1/hour, compared to 2 patients (16.7%) in the control group ( P =0.097). Conclusion Adenotonsillectomy with pillar suturing showed significant improvement in treating pediatric patients with OSAS compared to adenotonsillectomy alone. The procedure is simple and safe. Level of Evidence 4. Laryngoscope , 123:2574–2578, 2013
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Gilman, Elizabeth A. , Koch, Christopher D. , Santrach, Paula J., Schears, Gregory J. , Karon, Brad S.

American Journal of Clinical Pathology | July 29, 2013 | Volume: 140 | Issue: 2 | Pages: 165-169

10.1309/ajcpyiq9jnnsen4q | PMID 23897250 Get It

Abstract Objectives: To compare thromboelastography (TEG) tracings obtained from fresh and citrated whole-blood samples in patients on extracorporeal membrane oxygenation (ECMO) or after cardiopulmonary bypass and in healthy volunteers. Methods: Samples of fresh and citrated whole blood were analyzed for 25 patients and 4 healthy volunteers. Thromboelastography analysis was performed in both plain and heparinase cups. Results: In 5 of 6 patients on ECMO, use of citrated samples resulted in apparent partial or complete heparin reversal. In TEG tracings from patients following cardiopulmonary bypass, there was a slight hypercoagulable appearance in the citrated sample. No differences were noted between fresh and citrated samples from healthy volunteers whose blood was spiked with heparin. Conclusions: In some patients on ECMO, use of samples collected in sodium citrate tubes for TEG analysis results in significant artifacts, which could lead to heparin overdosing in these patients.
Understanding the course of Peyronie's disease
Garaffa, Giulio , Trost, Landon , Şerefoğlu, Ege Can , Ralph, David , Hellstrom, Wayne J.G.

International Journal of Clinical Practice | July 22, 2013 | Volume: 67 | Issue: 8 | Pages: 781-788

10.1111/ijcp.12129 | PMID 23869679 Get It

Can mechanical balloon dissection be applied to cleave fibrotic submucosal tissues? A pilot study in a porcine model
Dobashi, Akira , Sumiyama, Kazuki , Gostout, C. J., Ohya, Tomohiko R. , Kobayashi, Masakuni , Imazu, Hiroo , Tajiri, Hisao

Endoscopy | June 27, 2013 | Volume: 45 | Issue: 08 | Pages: 661-666

10.1055/s-0033-1344126 | PMID 23807802 Get It

I Can't Make Heads Or Tails Out Of What You Are Saying, So Let's Just Agree To Be Fair
Carter, Rickey E. , Carter, Rickey E

Teaching Statistics | June 25, 2013 | Volume: 35 | Issue: 3 | Pages: 127-130

10.1111/test.12013 Get It

SummaryAssuming a coin is fair is common place in introductory statistical education. This article offers three approaches to test if a coin is fair. The approaches lend themselves to straightforward simulation studies that can enrich student understanding of joint probability and sample size requirements. Simulation studies comparing the relative merits of the three, or potential other, approaches are an example of problem‐based learning.
Epilepsy Misdiagnosed as Long QT Syndrome: It Can Go Both Ways
Medford, Beth A., Bos, J. Martijn , Ackerman, Michael J. , Bos, Johan M

Congenital Heart Disease | June 10, 2013 | Volume: 9 | Issue: 4 | Pages: E135-E139

10.1111/chd.12104 | PMID 23750755 Get It

What Can We Learn From Regional Vulnerability to amyloid-β Accumulation in Nondemented individuals?
Shinohara, Mitsuru , Bu, Guojun

Neurodegenerative Disease Management | May 29, 2013 | Volume: 3 | Issue: 3 | Pages: 187-189

10.2217/nmt.13.20 Get It

Can New-Onset Diabetes After Kidney Transplant Be Prevented?
Chakkera, Harini A. , Weil, E. Jennifer , Pham, Phuong-Thu, Pomeroy, Jeremy , Knowler, William C. , Pham, Phuong‐Thu T., Chakkera, Harini A

Diabetes Care | April 23, 2013 | Volume: 36 | Issue: 5 | Pages: 1406-1412

10.2337/dc12-2067 | PMID 23613600 Get It

Because the negative consequences of new-onset diabetes mellitus after transplantation (NODAT) diminish the significant gains of kidney transplantation, it is imperative to develop clinical interventions to reduce the incidence of NODAT. In this review, we discuss whether intensive lifestyle interventions that delay or prevent type 2 diabetes mellitus may decrease the incidence of NODAT. We examine the literature pertaining to incidence and timing of onset of NODAT, as well as the risk factors and pathophysiology that NODAT shares with type 2 diabetes mellitus, namely pathways related to increased insulin resistance and decreased insulin secretion. Our central hypothesis is that NODAT results from the same metabolic risk factors that underlie type 2 diabetes mellitus. These risk factors are altered and enhanced by transplantation, “tipping” some transplant recipients with seemingly normal glucose homeostasis before transplant toward the development of NODAT. We describe the diabetogenic properties of transplant immunosuppressive drugs. We describe novel methods of prevention that are being explored, including resting the pancreatic β-cells by administration of basal insulin during the period immediately after transplant. On the basis of the current evidence, we propose that intensive lifestyle modification, adapted for individuals with chronic kidney disease or end-stage renal disease, as well as resting pancreatic β-cells during the immediate postoperative period, may lower the incidence of NODAT.
Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials
Ferreira‐González, Ignacio , Permanyer-Miralda, Gaieta, Busse, Jason W., Devereaux, P. J., Guyatt, Gordon H., Alonso-Coello, Pablo, Montori, Victor M., Busse, Jason W. , Permanyer-Miralda, Gaieta, Busse, Jason W., Devereaux, P. J., Guyatt, Gordon H., Alonso-Coello, Pablo, Montori, Victor M.

Annals of Internal Medicine | April 12, 2013 | Volume: 150 | Issue: 8 | Pages: 566-567

10.7326/0003-4819-150-8-200904210-00016 | PMID 19380859 Get It